500
F. Paradisi et al. / Tetrahedron: Asymmetry 13 (2002) 497–502
4.2. (1%S)-1,4-Bis-[N-1%-phenethyl)]-piperazine-2,5-dione
4.5.3. (1S,4R,1%S)-2,5-Bis-[N-(1%-phenethyl)]-3,6-dioxo-1-
methoxymethyl-bicyclo[3,2,2]nonane 4c. The product
was obtained by alkylating 2 with bromomethyl methyl
1
1
The product was prepared following the procedure
reported in Ref. 10.
ether (see entry 4 in Table 1). H NMR l: 0.6 (m, 1H);
1.46 (d, 3H, J=7); 1.6 (m, 5H); 1.8 (d, 3H, J=7); 3.38
(s, 3H); 3.69 (dd, 1H, J=3, 4.8); 3.86 (d, 1H, J=11.4);
4.02 (d, 1H, J=11.4); 4.86 (q, 1H, J=7.0); 5.95 (q, 1H,
J=7); 7.3 (m, 10ArH). 13C NMR l: 16, 16.9, 20.3,
24.8, 30.1, 50.5, 53.7, 54.9, 58.8, 66, 73.2, 125.6, 125.9,
127.6, 127.8, 128.3, 138.7, 142.3, 168.2, 169.7. [h]D
−191.3 (c 1.15, CHCl3). Anal. calcd for C25H30N2O3: C,
73.86; H, 7.44; N, 6.89. Found: C, 73.88; H, 7.46; N,
6.92%.
4.3. (1R,4R,1%S)-2,5-Bis-[N-(1%-phenethyl)]-2,5-diaza-
3,6-dioxo-bicyclo[3,2,2]nonane 2
The product was prepared following the procedure
reported in Ref. 2. For NMR spectra and [h]D value see
Ref. 1.
4.5.4. (1S,4R,1%S)-2,5-Bis-[N-(1%-phenethyl)]-1-allyl-3,6-
dioxo-bicyclo[3,2,2]nonane 4d. The product was
obtained by alkylating 2 with allyl bromide (see entry 2
in Table 1). 1H NMR l: 0.7 (m, 1H); 1.53 (d, 3H,
J=7); 1.4–2 (m, 5H); 1.83 (d, 3H, J=7); 2.89 (dd, 1H,
J=7.8, 16); 3.08 (dd, 1H, J=5.6, 16); 3.76 (dd, 1H,
J=3.4, 4.8 Hz); 4.96 (q, 1H, J=7); 5.05–5.2 (m, 2H);
5.9–6.15 (m, 2H); 7.2–7.45 (m, 10ArH). 13C NMR l:
16.3, 17.4, 20.8, 24.9, 34.5, 40.7, 50.9, 53, 55, 65.6,
118.7, 125.5, 126.1, 127.8, 128, 128.5, 133.5, 138.9,
141.8, 169.2, 170.6. [h]D −182.7 (c 0.79, CHCl3). Anal.
calcd for C26H30N2O2: C, 77.58; H, 7.51; N, 6.96.
Found: C, 77.45; H, 7.48; N, 6.97%.
4.4. (1S,4S,1%S)-2,5-Bis-[N-(1%-phenethyl)]-2,5-diaza-3,6-
dioxo-bicyclo[3,2,2]nonane 3
The product was prepared following the procedure
reported in Ref. 2. For NMR spectra and [h]D value see
Ref. 1.
4.5. Alkylation of 2 and 3: general procedure
A stirred solution of 2 or 3 (0.8 g, 2.1 mmol) in dry
THF (30 mL) cooled to −78°C was treated with base
(see Table 1). After about 5 min, the appropriate
alkylating reagent (see Table 1) was added and the
reaction was then monitored by TLC. When the reac-
tion was practically complete, the mixture was allowed
to warm to room temperature with stirring. Dilute
aqueous HCl and ethyl acetate were added and after
separation, the organic solution was evaporated in
vacuo. The residue was purified by silica gel chro-
matography eluting with hexane/ethyl acetate.
4.5.5. (1S,4S,1%S)-2,5-Bis-[N-(1%-phenethyl)]-3,6-dioxo-1-
methyl-bicyclo[3,2,2]nonane 5. The product was
obtained by alkylating 3 with iodomethane (see entry 9
1
in Table 1). H NMR l 1.38 (bs, 3H); 1.57 (d, 3H,
J=7.2); 1.6–2 (m, 6H); 1.74 (d, 3H, J=7.2); 3.83 (bs,
1H); 5.6–6 (bs, 1H); 5.88 (q, 1H, J=7.2); 7.17–7.4 (m,
10ArH). 13C NMR l: 16.8, 18.1, 21.4, 23.3, 27, 36.3,
51.2 (broad), 55.4, 63.6, 126.8, 126.9, 128, 128.4, 128.8,
140.2, 142.2, 170.5, 170.9. [h]D −39 (c 0.51, CHCl3).
Anal. calcd for C24H28N2O2: C, 76.56; H, 7.5; N, 7.44.
Found: C, 76.79; H, 7.52; N, 7.42%.
4.5.1. (1R,4R,1%S)-2,5-Bis-[N-(1%-phenethyl)]-3,6-dioxo-
1-methyl-bicyclo[3,2,2]nonane 4a. The product was
obtained by alkylating 2 with iodomethane (see entry 1
1
in Table 1). H NMR l: 0.8–1.8 (m, 6H); 1.51 (d, 3H,
4.5.6. (1S,4S,1%S)-2-N-(1%-Phenethyl)-5-N-(1¦-phenyliso-
propyl)-3,6-dioxo-bicyclo[3,2,2]nonane 6. The product
was obtained by alkylating 3 with iodomethane (see
entry 6 or 10 in Table 1). After chromatographic sepa-
ration the product was not isolated in pure enough
form to measure the specific rotation and to obtain
satisfactory elemental analysis. 1H NMR l: 1.57 (d,
3H, J=7.2); 1.6–2.05 (m, 6H); 1.66 (s, 3H); 1.85 (s,
3H); 3.65 (t, 1H, J=4); 4.28 (t, 1H, J=4); 5.83 (q, 1H,
J=7.2); 7.3 (m, 10ArH); 13C NMR l: 17, 20, 26.6,
26.9, 27.1, 29.8, 50.4, 56.9, 57.8, 62, 124.6, 126.6, 126.8,
127.8, 128.3, 128.7, 139.9, 146.5, 169, 169.6.
J=6.9); 1.67 (s, 3H); 1.83 (d, 3H, J=7.2); 3.79 (bs,
1H); 5 (m, 1H); 5.96 (q, 1H, J=7.2); 7.3 (m, 10ArH).
13C NMR l: 16.1, 18, 20.9, 23.4, 24.7, 35.7, 51, 52.7,
55.2, 63.6, 125.7, 126.5, 127.7, 127.9, 128, 128.4, 138.8,
141.7, 169.8, 170.2. [h]D −154.5 (c 0.71, CHCl3). Anal.
calcd for C24H28N2O2: C, 76.56; H, 7.5; N, 7.44. Found:
C, 76.79; H, 7.52; N, 7.42%.
4.5.2.
(1S,4R,1%S)-2,5-Bis-[N-(1%-phenethyl)]-1-benzyl-
3,6-dioxo-bicyclo[3,2,2]nonane 4b. The product was
obtained by alkylating 2 with benzyl bromide (see entry
3 in Table 1). 1H NMR l: 0.7 (m, 1H); 1.4–1.7 (m, 5H);
1.65 (d, 3H, J=7); 1.79 (d, 3H, J=7); 3.26 (d, 1H,
J=16); 3.91 (dd, 1H, J=3, 4.8); 4 (d, 1H, J=16); 5
(broad, 1H); 6.01 (q, 1H, J=7); 6.8–7.5 (m, 15ArH).
13C NMR l: 16.7, 18.7, 20.6, 25, 34.4, 41.5, 51.4, 54.2,
55.1, 67.7, 125.8, 126, 126.3, 127.4, 128, 128.1, 128.2,
128.6, 130.2, 135.8, 138.9, 141.3, 169.6, 171.2. [h]D
−194.7 (c 0.59, CHCl3). Anal. calcd for C30H32N2O2: C,
79.61; H, 7.13; N, 6.19. Found: C, 79.35; H, 7.15; N,
6.18%.
4.5.7. (1S,4S)-2,5-Bis-[N-(1%-phenylisopropyl)]-3,6-dioxo-
bicyclo[3,2,2]nonane 7. The product was obtained by
alkylating 3 with iodomethane (see entry 11 in Table 1).
1H NMR l: 1.64 (s, 6H); 1.6–2.1 (m, 6H); 1.91 (s, 6H);
4.1 (t, 2H, J=6); 7.3 (m, 10ArH). 13C NMR l: 19.8,
26.7, 29.8, 59.1, 61.5, 124.4, 126.6, 128.1, 146.5, 169.2.
[h]D 166.7 (c 0.66, CHCl3). Anal. calcd for C25H30N2O2:
C, 76.89; H, 7.74; N, 7.17. Found: C, 76.09; H, 7.75; N,
7.2%.